Sort
40,608 grants matching “prostate cancer”
NEW AWARD - TRANSGENIC T CELL IMMUNOTHERAPY TARGETING PROSTATE-RESTRICTED EPITHELIAL ANTIGENS IN PROSTATE CANCER, EFFECTIVE 3/1/2020, SIGNED 2/21/2020, DISTRIBUTED 2/24/2020, FAADC 2/24/2020
$350,141Fred Hutchinson Cancer Research Center · · FY2020 · Defense Health Agency
EphB2 as a Prostate Cancer tumor Suppressor and Risk Factor in African Americans
$350,101John David Carpten · Translational Genomics Research Inst · R01 · FY2006 · CA
DEVELOPMENT OF A NOVEL METHOD OF DETECT PROSTATE CANCER CIRCULATING TUMOR CELLS (CTCS) BASED ON EPITHELIAL-MESENCHMYMAL TRANSITION BIOLOGY
$350,100Duke University · · FY2012 · Department of the Army
THE ROLE OF NF-KAPPAB SIGNALING IN THE BONE METASTASIS OF PROSTATE CANCER
$350,085Vanderbilt University, The · · FY2010 · Department of Defense
Implementation of evidence-based cancer early detection in Black churches
$350,075Cheryl L Holt · Univ Of Maryland, College Park · R01 · FY2016 · CA
Project 2 - Clinical translation
$350,064Robert A Gatenby · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2015 · CA
NextGen Lab-on-Bead: Harnessing Ion Torrent Sequencing for Cancer Drug Discovery
$350,000Roger Cubicciotti · Nanomedica, Llc · R43 · FY2013 · GM
Attenuation of androgen deprivation therapy-induced metabolic syndrome by diet
$350,000Oleg Varlamov · Oregon Health & Science University · R21 · FY2013 · AG
Patient Perspectives on Relabeling and Pathology Reporting for Grade Group 1 Prostate Cancer
$350,000Jesus Ramirez-Valles · University Of California, San Francisco · U48 · FY2024 · DP
ULTRASMALL PSMA-TARGETED PARTICLE RADIOTHERAPY FOR REGULATING THE IMMUNOSUPPRESSIVE PROSTATE CANCER TUMOR MICROENVIRONMENT AND ENHANCING TREATMENT EFFICACY
$350,000Cornell University · · FY2025 · Defense Health Agency
Anti-CCL25 mAb to treat castration resistant prostate cancer
$350,000Shailesh Singh · Jyant, Inc. · R41 · FY2017 · CA
UNIVERSITY OF ROCHESTER--CCOP RESEARCH BASE
$350,000University Of Rochester · U10 · FY2000 · CA
University of Texas SPORE in Prostate Cancer
$350,000Christopher J. Logothetis · University Of Tx Md Anderson Can Ctr · P50 · FY2007 · CA
DP24-062 (SIPS), Patient Perspectives on Relabeling and Pathology Reporting for Grade Group 1 Prostate Cancer
$350,000Jesus Ramirez-Valles · University Of California, San Francisco · U48 · FY2025 · DP
High-specificity affinity reagents for the detection of glycan sialylation
$349,995Loretta Yang · Lectenz Bio, Inc. · R44 · FY2020 · GM
MAOA and AR Reciprocal Crosstalk in Prostate Cancer
$349,988Boyang Wu · Washington State University · R37 · FY2019 · CA
Effective Anti-Tumor Vaccination - Targeting Checkpoint Regulation at the Time of T-cell Activation
$349,988Douglas G McNeel · University Of Wisconsin-Madison · R01 · FY2018 · CA
Effective Anti-Tumor Vaccination - Targeting Checkpoint Regulation at the Time of T-cell Activation
$349,988Douglas G McNeel · University Of Wisconsin-Madison · R01 · FY2017 · CA
MAOA and AR Reciprocal Crosstalk in Prostate Cancer
$349,988Boyang Wu · Washington State University · R37 · FY2025 · CA
Mechanisms of Radioresistance and Cell Cycle Progression
$349,988Howard B Lieberman · Columbia University Health Sciences · R01 · FY2011 · CA
Effective Anti-Tumor Vaccination - Targeting Checkpoint Regulation at the Time of T-cell Activation
$349,988Douglas G McNeel · University Of Wisconsin-Madison · R01 · FY2021 · CA
MAOA and AR Reciprocal Crosstalk in Prostate Cancer
$349,988Boyang Wu · Washington State University · R37 · FY2020 · CA
Targeting Mitochondrial Redox Capacity to Overcome Cancer Subtype that Regrowth After Radiation
$349,988Luksana Chaiswing · University Of Kentucky · R01 · FY2025 · CA
Targeting Mitochondrial Redox Capacity to Overcome Cancer Subtype that Regrowth After Radiation
$349,988Luksana Chaiswing · University Of Kentucky · R01 · FY2021 · CA
MAOA and AR Reciprocal Crosstalk in Prostate Cancer
$349,988Boyang Wu · Washington State University · R37 · FY2021 · CA